A detailed history of Verum Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Verum Partners LLC holds 731 shares of LLY stock, worth $693,280. This represents 0.21% of its overall portfolio holdings.

Number of Shares
731
Previous 720 1.53%
Holding current value
$693,280
Previous $560 Million 18.2%
% of portfolio
0.21%
Previous 0.2%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $7,973 - $9,999
11 Added 1.53%
731 $662 Million
Q1 2024

Apr 18, 2024

SELL
$592.2 - $792.28 $11,844 - $15,845
-20 Reduced 2.7%
720 $560 Million
Q4 2023

Jan 18, 2024

SELL
$525.19 - $619.13 $7,877 - $9,286
-15 Reduced 1.99%
740 $431 Million
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $103,458 - $142,633
238 Added 46.03%
755 $406 Million
Q2 2023

Jul 24, 2023

BUY
$350.74 - $468.98 $181,332 - $242,462
517 New
517 $242 Million
Q4 2022

Jan 25, 2023

BUY
$321.55 - $374.67 $200,325 - $233,419
623 New
623 $228 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $901B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Verum Partners LLC Portfolio

Follow Verum Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verum Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verum Partners LLC with notifications on news.